The global biliary stents market was valued at USD 112 million in 2016 and is expected to surpass USD 137 million by 2021, says Technavio.
Technavio has announced its latest market research report on the global biliary stents market, under its orthopedics and medical devices portfolio. This market analysis discusses the key drivers and chief emerging trends and offers a competitive analysis of main vendors like Abbott Vascular, Boston Scientific, Cook Medical, C. R. Bard, Medtronic, and Taewoong Medical.
According to Sapna Jha, a lead analyst for orthopedics and medical devices research at Technavio, “The growing preference for MI procedures to drive growth in the global biliary stents market. There has been an increase in the popularity of MI procedures for the treatment of biliary diseases such as gallbladder stones, pancreas-related diseases, etc. .”
These procedures are advanced and are becoming increasingly popular as they deliver superior results with minimal complications. Biliary stent intervention is one such MI procedure that does not involve open surgery. The surgeons use imaging technology to guide instruments inside the body. Thus, the growing shift toward MI techniques over conventional surgical bypass methods will increase the demand for biliary stents during the forecast period.
Click here to request a free sample of this report
Growing demand for bioabsorbable stents
The introduction of new stents with bioabsorbable stents and biodegradable polymers are projected to increase the utilization of stents in biliary stents. These stents have the potential to minimize the risks associated with durable polymer stents. Owing to their potential, vendors are focusing on developing self-expandable bioabsorbable stents. For instance, Boston Scientific uses biodegradable polymer (polylactic acid) for its WallFlex Biliary RX Stent, a bioabsorbable used for biliary walls.
Technological advancements
Advances in stent design, material, and technology have enabled the introduction of specially-designed stents that can be used for specific conditions. Materials that are introduced recently include polycaprolactone, polylactic acid-glycolic acid, and poly acryl amine. These biodegradable materials have advantages, such as the elimination of stent removal and biocompatibility. The use of SEMS (self-expandable metal stent) for treating anastomotic leaks and perforations seem to be promising, which began their evolution with plastic but soon evolved into biodegradable expandable stents. For instance, Boston Scientific offers Advanix biliary stent with NaviFlex RX Delivery System, WallFlex Biliary Transhepatic Series, Express LD Biliary Premounted Stent System, and Express SD Biliary Monorail Premounted Stent System that are used in the treatment of biliary-related diseases.
Ask an analyst to know more about this report
This market research report includes an in-depth analysis and market shares and sizes of the sub-segments and geography. A competitive analysis of the key vendors, including their market shares, business overview, key financials, etc. is provided in this study. This market study also provides a detailed analysis of key drivers, challenges, and opportunities influencing this market.
A more detailed analysis is available in the Technavio report titled, ‘Global Biliary Stents Market 2017-2021‘. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Gastrointestinal Stents Market 2016-2020
- Global Non-Vascular Stents Market 2016-2020
- Global Gastrointestinal Therapeutics Market 2016-2020
To read more press releases – click here
